返回
T-Cell Lymphomas, Version 2.2022
DOI:10.6004/jnccn.2022.0015.png)
摘要
En 中文
Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of lymphoproliferative disorders arising from mature T cells, accounting for about 10% of non-Hodgkin lymphomas. PTCL-not otherwise specified is the most common subtype, followed by angioimmunoblastic T-cell lymphoma, anaplastic large cell lymphoma, anaplastic lymphoma kinase-positive, anaplastic large cell lymphoma, anaplastic lymphoma kinase-negative, and enteropathy-associated T-cell lymphoma. This discussion section focuses on the diagnosis and treatment of PTCLs as outlined in the NCCN Guidelines for T-Cell Lymphomas. J Natl Compr Canc Netw 2022;20(3):285-308 doi: 10.6004/jnccn.2022.0015
Keyword:
POSITRON-EMISSION-TOMOGRAPHY
HIGH-DOSE CHEMOTHERAPY
PHASE-II TRIAL
NON-HODGKIN-LYMPHOMA
1ST COMPLETE REMISSION
LONG-TERM REMISSIONS
DETUDE DES LYMPHOMES
PROGNOSTIC-FACTORS
WORKING PARTY
ALLOGENEIC TRANSPLANTATION
期刊
J
IF:
16.4
论文数:
2.8K
被引数:
1.5W
机构
引用论文
Utility of 18fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphoma
ANNALS OF ONCOLOGY
IF65.4
The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission:: the Spanish Lymphoma and Autologous Transplantation Group experience首次完全缓解的外周T细胞淋巴瘤 (PTCL) 患者的自体干细胞移植巩固结果: 西班牙淋巴瘤和自体移植小组的经验
ANNALS OF ONCOLOGY
IF65.4


